Geron (GERN) Stock Price
$1.27 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Geron, AI stock picks, stock alerts and much more.
GERN AI Stock Analysis
AI stock analysis for GERN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Geron (GERN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Geron (GERN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Geron (GERN), currently trading at $1.27, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GERN
-
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.
-
Symbol
GERN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
808.9M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
GERN Alternative Data
Web Traffic
Geron receives an estimated 8883 monthly visitors to geron.com.
-
Web Traffic
8883
-
Change from Previous Month
16.3%
-
3 Month Change
32.7%
-
YoY Change
32.7%
News Mentions
Geron was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
75%
-
1 Month Change
50%
-
3 Month Change
0%
Reddit Mentions
Geron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Followers
16,443 are following Geron on LinkedIn, up by 3.8% over the last month.
-
LinkedIn Followers
16443
-
Daily Change
0%
-
1 Month Change
3.8%
-
3 Month Change
11.8%
Job Postings
Geron currenly has an estimated 17 open job postings, up by 21.4% over the last month.
-
Job Postings
17
-
Daily Change
30.8%
-
1 Month Change
21.4%
-
3 Month Change
88.9%
-
YoY Change
88.9%
LinkedIn Employees
According to LinkedIn, Geron has 381 employees.
-
LinkedIn Employees
381
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.1%
-
YoY Change
2.1%
Business Outlook
According to employee reviews, the business outlook among employees at Geron is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
GERN Financials
GERN Key Metrics
-
Total Revenue
$47.5M
-
Net Income
-$25.4M
-
Earnings per Share
-$0.0392
-
Free cash flow
-$43.8M
-
EBITDA
-$16.3M
-
EBITDA Ratio
-0.343522
-
Total Assets
$593.8M
GERN 2-year Revenue & Income
GERN 2-year Free Cash Flow
GERN Technicals
GERN SMA
GERN RSI
FAQ
What's the current price of Geron (GERN) Stock?
The price of an Geron (GERN) share is $1.27.
What's the market cap of Geron?
The current market cap of Geron is 808.9M.
Should I buy or sell GERN?
Geron exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Geron a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Geron stock. There are several bearish signals and market challenges that could negatively impact Geron's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Geron (GERN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Geron stock right now, as the outlook appears bearish.
What are some stocks similar to Geron (GERN) that investors often compare it to?
Geron (GERN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Geron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Geron's stock price to be around $1.18 in 2026. Starting from the current price of $1.27, this represents a 7.5% change in price, indicating a bearish outlook for the stock.
How to buy Geron (GERN) Stock?
Geron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Geron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.